EUR 0.21
(0.48%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2022 | -860.59 Thousand EUR | 99.64% |
2021 | -241.5 Thousand EUR | 63.38% |
2020 | -659.51 Thousand EUR | 26.75% |
2019 | -900.37 Thousand EUR | -114835.18% |
2018 | -783.37 Thousand EUR | 23.52% |
2017 | -1.06 Million EUR | -210.03% |
2016 | 930.91 Thousand EUR | 287.46% |
2015 | -495.33 Thousand EUR | 15.2% |
2014 | -585.6 Thousand EUR | 99.95% |
2013 | -1.12 Million EUR | 27.71% |
2012 | -1.54 Million EUR | -23.49% |
2011 | -1.25 Million EUR | 17.66% |
2010 | -1.52 Million EUR | -20.17% |
2009 | -1.26 Million EUR | 18.21% |
2008 | -2.5 Million EUR | -22.32% |
2007 | -1.27 Million EUR | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 Q2 | - EUR | 0.0% |
2022 Q2 | -228.49 Thousand EUR | 0.0% |
2022 Q4 | -665.30 EUR | 0.0% |
2022 FY | - EUR | 99.64% |
2021 Q2 | -96.13 Thousand EUR | 0.0% |
2021 Q4 | -144.98 Thousand EUR | 0.0% |
2021 FY | - EUR | 63.38% |
2020 FY | - EUR | 26.75% |
2020 Q2 | -305.02 Thousand EUR | 0.0% |
2020 Q4 | -354.5 Thousand EUR | 0.0% |
2019 Q2 | -416.39 Thousand EUR | 0.0% |
2019 FY | - EUR | -114835.18% |
2019 Q4 | -483.98 Thousand EUR | 0.0% |
2018 FY | - EUR | 23.52% |
2018 Q4 | -460.61 EUR | 0.0% |
2018 Q2 | -322.76 EUR | 0.0% |
2017 Q2 | -60.03 EUR | 0.0% |
2017 Q4 | -1024.26 EUR | 0.0% |
2017 FY | - EUR | -210.03% |
2016 FY | - EUR | 287.46% |
2016 Q4 | 1080.58 EUR | 0.0% |
2016 Q2 | -149.66 EUR | 0.0% |
2015 Q4 | -260.42 EUR | 0.0% |
2015 FY | - EUR | 15.2% |
2015 Q2 | -236.18 EUR | 0.0% |
2014 Q4 | -338.47 EUR | 0.0% |
2014 Q2 | -247.14 EUR | 0.0% |
2014 FY | - EUR | 99.95% |
2013 Q3 | -299.53 Thousand EUR | -40957.32% |
2013 Q4 | -391.64 EUR | 99.87% |
2013 Q2 | -729.54 EUR | 99.76% |
2013 FY | - EUR | 27.71% |
2013 Q1 | -299.53 Thousand EUR | 0.0% |
2012 Q3 | -387.24 Thousand EUR | 0.0% |
2012 FY | - EUR | -23.49% |
2012 Q1 | -387.24 Thousand EUR | 0.0% |
2012 Q2 | -387.24 Thousand EUR | 0.0% |
2011 Q3 | -316.26 Thousand EUR | 0.0% |
2011 Q2 | -316.26 Thousand EUR | 0.0% |
2011 Q1 | -316.26 Thousand EUR | 0.0% |
2011 FY | - EUR | 17.66% |
2010 Q2 | -288.16 Thousand EUR | 0.0% |
2010 Q3 | -288.16 Thousand EUR | 0.0% |
2010 Q1 | -288.16 Thousand EUR | 0.0% |
2010 FY | - EUR | -20.17% |
2009 FY | - EUR | 18.21% |
2009 Q3 | -469.26 Thousand EUR | 0.0% |
2009 Q2 | -469.26 Thousand EUR | 0.0% |
2009 Q1 | -469.26 Thousand EUR | 0.0% |
2008 Q1 | -666.11 Thousand EUR | 0.0% |
2008 Q2 | -666.11 Thousand EUR | 0.0% |
2008 Q3 | -666.11 Thousand EUR | 0.0% |
2008 FY | - EUR | -22.32% |
2007 Q2 | -363.48 Thousand EUR | 0.0% |
2007 Q1 | -363.48 Thousand EUR | 0.0% |
2007 Q3 | -363.48 Thousand EUR | 0.0% |
2007 FY | - EUR | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
aap Implantate AG | -3.43 Million EUR | 74.924% |
Drägerwerk AG & Co. KGaA | 318.33 Million EUR | 100.27% |
Drägerwerk AG & Co. KGaA | 318.33 Million EUR | 100.27% |
Eckert & Ziegler Strahlen- und Medizintechnik AG | 57.48 Million EUR | 101.497% |
Geratherm Medical AG | 4.18 Million EUR | 120.567% |
Koninklijke Philips N.V. | 1.04 Billion EUR | 100.083% |
Stratec SE | 39.82 Million EUR | 102.161% |
Siemens Healthineers AG | 4.22 Billion EUR | 100.02% |